Title |
Cyclophosphamide-induced posterior reversible encephalopathy syndrome (PRES): a case report
|
---|---|
Published in |
Journal of Medical Case Reports, December 2014
|
DOI | 10.1186/1752-1947-8-442 |
Pubmed ID | |
Authors |
Jayamalee L Jayaweera, Milinda R Withana, Chamila KP Dalpatadu, Chathurika D Beligaswatta, Thamara Rajapakse, Saroj Jayasinghe, Thashi Chang |
Abstract |
Posterior reversible encephalopathy syndrome is a clinicoradiologic entity characterized by headache, seizures, decreased vision, impaired consciousness and white matter oedema in bilateral occipitoparietal regions. Hypertensive encephalopathy, eclampsia, immunosuppressive/cytotoxic drugs, organ transplantation, renal disease, autoimmune diseases and vasculitides are reported risk factors of posterior reversible encephalopathy syndrome. Reports of cyclophosphamide-induced posterior reversible encephalopathy syndrome are rare and occurred in a background of renal failure, fluid overload or active connective tissue disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 20 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 5 | 25% |
Researcher | 3 | 15% |
Student > Bachelor | 2 | 10% |
Professor | 2 | 10% |
Lecturer > Senior Lecturer | 1 | 5% |
Other | 3 | 15% |
Unknown | 4 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 55% |
Agricultural and Biological Sciences | 2 | 10% |
Biochemistry, Genetics and Molecular Biology | 1 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Neuroscience | 1 | 5% |
Other | 0 | 0% |
Unknown | 4 | 20% |